Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1)

Clinical trial NCT02149108 · COMPLETED

Trial details

NCT number: NCT02149108
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Colorectal Neoplasms

Start date: 2014-09-25
Primary completion: 2016-05-13
Enrollment: 768

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.